Literature DB >> 18053340

HIV-related pulmonary disorders: practice issues.

S M Graham1.   

Abstract

Pulmonary disease is the major cause of morbidity and mortality in infants and children infected with the human immunodeficiency virus (HIV). Diagnosis and management is often difficult in the resource-limited setting, especially as most HIV-related pulmonary disease presents in infancy or early childhood. Knowledge of the causes of pulmonary disease in HIV-infected children in that setting has improved considerably over the last decade, as has the availability of effective treatment for all HIV-infected children, such as cotrimoxazole preventive therapy and antiretroviral therapy. Important causes of acute bacterial pneumonia in HIV-infected children include bacteria such as pneumococci, gram-negatives and staphylococci. Pneumocystis pneumonia is particularly common in HIV-infected infants and a common cause of death. Cytomegalovirus is also found frequently in infants with pneumonia, often as a co-infection with PcP. Tuberculosis (TB) is increasingly recognised as a common cause of acute pneumonia as well as chronic pulmonary disease in regions endemic for TB/HIV. Other important causes of chronic lung disease in HIV-infected children include lymphocytic interstitial pneumonitis and bronchiectasis. This review aims to address practical issues that health workers often face in the management of acute or chronic pulmonary disease presenting in HIV-infected children in the resource-limited setting.

Entities:  

Mesh:

Year:  2007        PMID: 18053340     DOI: 10.1179/146532807X245625

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  12 in total

Review 1.  Pneumococcal vaccine and patients with pulmonary diseases.

Authors:  Mehdi Mirsaeidi; Golnaz Ebrahimi; Mary Beth Allen; Stefano Aliberti
Journal:  Am J Med       Date:  2014-05-20       Impact factor: 4.965

2.  Dysregulation of claudin-5 in HIV-induced interstitial pneumonitis and lung vascular injury. Protective role of peroxisome proliferator-activated receptor-γ.

Authors:  Hong Li; Sangya Singh; Raghava Potula; Yuri Persidsky; Georgette D Kanmogne
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

3.  Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis.

Authors:  M Vetter; M Battegay; M Trendelenburg
Journal:  Infection       Date:  2010-08       Impact factor: 3.553

4.  Brief Report: Cofactors of Mortality Among Hospitalized HIV-Infected Children Initiating Antiretroviral Therapy in Kenya.

Authors:  Irene N Njuguna; Lisa M Cranmer; Anjuli D Wagner; Sylvia M LaCourse; Cyrus Mugo; Sarah Benki-Nugent; Barbra A Richardson; Joshua Stern; Elizabeth Maleche-Obimbo; Dalton C Wamalwa; Grace John-Stewart
Journal:  J Acquir Immune Defic Syndr       Date:  2019-06-01       Impact factor: 3.731

Review 5.  Challenges to improving case management of childhood pneumonia at health facilities in resource-limited settings.

Authors:  Stephen M Graham; Mike English; Tabish Hazir; Penny Enarson; Trevor Duke
Journal:  Bull World Health Organ       Date:  2008-05       Impact factor: 9.408

6.  Development of the Respiratory Index of Severity in Children (RISC) score among young children with respiratory infections in South Africa.

Authors:  Carrie Reed; Shabir A Madhi; Keith P Klugman; Locadiah Kuwanda; Justin R Ortiz; Lyn Finelli; Alicia M Fry
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

7.  Pneumocystis pneumonia in South African children diagnosed by molecular methods.

Authors:  Brenda M Morrow; Catherine M Samuel; Marco Zampoli; Andrew Whitelaw; Heather J Zar
Journal:  BMC Res Notes       Date:  2014-01-10

8.  The immune response and its therapeutic modulation in bronchiectasis.

Authors:  Massoud Daheshia; James D Prahl; Jacob J Carmichael; John S Parrish; Gilbert Seda
Journal:  Pulm Med       Date:  2012-10-10

9.  Multiple sampling in one day to optimize smear microscopy in children with tuberculosis in Yemen.

Authors:  Nasher Al-Aghbari; Najla Al-Sonboli; Mohammed A Yassin; John B S Coulter; Zayed Atef; Ali Al-Eryani; Luis E Cuevas
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

10.  Interstitial lung disease associated with Equine Infectious Anemia Virus infection in horses.

Authors:  Pompei Bolfa; Marie Nolf; Jean-Luc Cadoré; Cornel Catoi; Fabienne Archer; Christine Dolmazon; Jean-François Mornex; Caroline Leroux
Journal:  Vet Res       Date:  2013-12-01       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.